Fish oil and rheumatoid arthritis: past, present and future (Q37761399)

22 August 2017

1 reference

title

Fish oil and rheumatoid arthritis: past, present and future (English)

1 reference

22 August 2017

1 reference

1 reference

0 references

Michael James

1

1 reference

22 August 2017

Susanna Proudman

series ordinal

2

1 reference

22 August 2017

Les Cleland

series ordinal

3

1 reference

22 August 2017

language of work or name

1 reference

28 May 2010

1 reference

Proceedings of the Nutrition Society

22 August 2017

1 reference

22 August 2017

69

1 reference

22 August 2017

3

1 reference

22 August 2017

316-323

1 reference

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

22 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Dietary n-3 fatty acids and therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Effect of dietary oils on the production of n-3 and n-6 metabolites of leukocyte 5-lipoxygenase in five rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Biosynthesis of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Neutrophil-derived leukotriene B4 is required for inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Prostaglandins as inflammatory messengers across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Pain modulatory actions of cytokines and prostaglandin E2 in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Blood levels of long-chain n-3 fatty acids and the risk of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Effects of fish oil supplementation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Cardiovascular co-morbidity in early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Pharmacological analysis of cyclooxygenase-1 in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n−3 fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

EFFECTS OF FISH OIL SUPPLEMENTATION ON NON-STEROIDAL ANTI—INFLAMMATORY DRUG REQUIREMENT IN PATIENTS WITH MILD RHEUMATOID ARTHRITIS—A DOUBLE-BLIND PLACEBO CONTROLLED STUDY

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Separation and quantification of PGE3 following derivatization with pancyl bromide by high pressure liquid chromatography with fluorometric detection

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

COMET results are not stellar

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110001564

7 January 2021

10.1017/S0029665110001564

Identifiers

DOI

1 reference

22 August 2017

1 reference